Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
64.25
+0.31 (+0.48%)
Streaming Delayed Price
Updated: 10:42 AM EDT, Sep 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
June 18, 2024
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...
Via
Benzinga
Exposures
COVID-19
The RBA Kept Interest Rates On Hold And Remained Hawkish
June 18, 2024
The Reserve Bank of Australia kept the cash rate at 4.35% at its June meeting, leaving borrowing costs unchanged for the fifth time.
Via
Talk Markets
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report
June 17, 2024
OpenAI and startup Color Health have developed an AI assistant, named 'copilot', to support physicians in creating personalized cancer care plans, emphasizing the tool's role in augmenting rather than...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna Just Gave Investors Another Reason to Buy the Stock
June 16, 2024
The company's post-pandemic prospects are getting brighter.
Via
The Motley Fool
7 Struggling Stocks to Sell Before July 2024
June 12, 2024
The stock market is riding high for now. But even a roaring bull market can't save these seven stocks to sell.
Via
InvestorPlace
Smart Money Is Betting Big In MRNA Options
June 11, 2024
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $800 Today
June 03, 2024
Via
Benzinga
Breaking Down Moderna: 7 Analysts Share Their Views
June 03, 2024
Via
Benzinga
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
June 11, 2024
After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.
Via
InvestorPlace
Exposures
Product Safety
What's Going On With Moderna Stock Monday?
June 10, 2024
Moderna said its Phase 3 trial of mRNA-1083, an investigational combination vaccine against influenza and COVID-19, met its primary endpoints.
Via
Benzinga
Exposures
COVID-19
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
June 10, 2024
Liz Young of SoFi recommends Energy Select Sector SPDR Fund as her final trade on CNBC's Halftime Report. Jim Lebenthal of Cerity Partners picks General Motors, while Jason Snipe of Odyssey Capital...
Via
Benzinga
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
June 10, 2024
If approved, this would be the first combination vaccine based on mRNA technology to hit the market.
Via
Investor's Business Daily
Exposures
COVID-19
Why Moderna Stock Is a No-Brainer Buy Right Now
June 10, 2024
This messenger-RNA pioneer should be able to keep its rebound going.
Via
The Motley Fool
3 Reasons to Buy Moderna Stock
June 08, 2024
The biotech hasn't said its last word.
Via
The Motley Fool
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
June 07, 2024
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.
Via
Benzinga
Exposures
COVID-19
Product Safety
5 Stocks Propelling S&P 500 To 25th Record High
June 06, 2024
While most of the stocks have performed well, here are five of them that led the way higher in yesterday's trading session.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
June 06, 2024
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.
Via
Benzinga
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program
June 06, 2024
Moderna's mRNA-370 has been selected for the FDA's START program to accelerate rare disease therapeutics, targeting a 2024 pivotal study.
Via
Benzinga
Exposures
Product Safety
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
June 06, 2024
Novavax will be ready for the new Covid-19 JN.1 variants in September, but NVAX stock is also undergoing a short squeeze.
Via
InvestorPlace
Exposures
COVID-19
Novavax, With A 369% Gain, Tears Ahead Again On Key FDA Move
June 06, 2024
Novavax also said it's planning to launch a JN.1-focused Covid booster shot this fall.
Via
Investor's Business Daily
Exposures
COVID-19
Product Safety
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
June 05, 2024
If you have the patience and the ability to take a little risk, consider these three biotech stocks to buy since they can really pay off.
Via
InvestorPlace
Why Is Novavax (NVAX) Stock Up 20% Today?
June 05, 2024
Novavax continues to march higher in its recovery efforts, with its latest vaccine announcement lifting NVAX stock.
Via
InvestorPlace
S&P 500, Nasdaq 100 Jointly Hit All-Time Highs, Nvidia Overtakes Apple As Second Most Valuable US Company
June 05, 2024
The S&P 500 and Nasdaq 100 indices closed at record highs due to investor confidence in AI-driven tech sector growth. Magnificent Seven worth $15T.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Novavax Stock?
June 05, 2024
Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at what's going on.
Via
Benzinga
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
June 04, 2024
On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co...
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
June 04, 2024
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate
Via
InvestorPlace
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma Patients
June 03, 2024
Moderna and Merck's Phase 2b study results for mRNA-4157 combined with Keytruda, showing improvements in recurrence-free and distant metastasis-free survival for high-risk melanoma patients. Phase 3...
Via
Benzinga
Is Moderna Stock a Buy Now That It's a 2-Product Company?
June 03, 2024
The Food and Drug Administration recently approved a new vaccine from Moderna, but the stock dipped in response.
Via
The Motley Fool
Moderna Investors Just Got Some Bullish News
June 03, 2024
This news could be worth billions...
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 31, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.